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Top-Priority 
Population
Current epidemiology 
estimates for pyoderma 
gangrenosum (PG) are 
based on case reports, case 
series, and cohort studies of 
patients with inflammatory 
bowel disease (IBD). Langan 
and colleagues performed a 
retrospective cohort study 
with computerized medical 
records from the General 
Practice Research Database 
in the United Kingdom. They 
found that PG mortality 
rates were three times 
higher than those for the 
general public. In addition, 
33% of the PG study 
population had underlying 
IBD, rheumatoid arthritis, 
or hematological disease. 
Because PG was identified 
as a top research priority by 
the UK Dermatology Clinical 
trials network, these findings 
will be particularly useful for 
planning future studies.  
See page 2166
Tipping the Scale
The popular assessment 
tool for disease sever­
ity, the Psoriasis Area and 
Severity Index (PASI), is 
typically used to evaluate 
the efficacy of therapeutic 
interventions. Gourraud and colleagues assessed the simulated evaluation of the 
PASI by two practitioners in 1,000 sets of 100 psoriasis patients in an effort to 
characterize the validity of this standardized scale. The study revealed an asym­
metry in PASI score distribution, with more than 75% of patients having scores 
<20 (range 0–72). Commonly used statistics (r and ρ) were found to over­
estimate the interrater agreement for this scale, although the intraclass correlation 
coefficient was superior. A reliable standardized assessment of psoriasis severity 
remains elusive. See page 2171
Temporary Senescence
Cellular senescence in response to aberrant 
oncogene activation is thought to function 
as a tumor suppressor. Human melanocytic 
nevi remain growth arrested, rarely develop 
into melanomas, and display features of 
oncogene­induced senescence. Tran and 
colleagues found that the senescence markers 
(upregulation of p16INK4a, senescence­
associated β­galactosidase positivity, and 
Ki67 negativity) occur in both fresh­frozen 
and paraffin­embedded nevi and melanomas. 
As a result, these markers fail to differentiate 
nevi from their precursor and transformed 
melanocyte counterparts. Benign nevi are, 
indeed, typically growth arrested; however, 
defining these benign melanocyte tumors as 
senescent is premature in the face of this new 
evidence. See page 2226
External Insight
Kidney transplant recipients (KTRs) have a greater risk of malignancy compared 
with the general population. In a cohort study of 1,800 KTR patients, Wisgerhof 
and colleagues discovered a threefold higher risk of internal malignancies (IMs) in 
KTRs with a prior cutaneous squamous cell carcinoma (SCC), whereas the risk of 
IM in KTRs without SCC was only marginally higher than that in the general popu­
lation. These findings suggest that development of cutaneous SCC may be a useful 
indicator of increased risk of IM in KTRs. See page 2176
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